The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Hospital Mortality

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Hospital Mortality


Psychiatry related information on Hospital Mortality


High impact information on Hospital Mortality

  • The in-hospital mortality rates in the t-PA and PTCA groups were 6.5 and 2.6 percent, respectively (P = 0.06) [7].
  • CONCLUSIONS--Patients with COPD admitted to an ICU for an acute exacerbation have a substantial hospital mortality (24%) [8].
  • The relation between hospital experience and in-hospital mortality for patients with AIDS-related PCP [9].
  • INTERPRETATION: The early use of NIV for mildly and moderately acidotic patients with COPD in the general ward setting leads to more rapid improvement of physiological variables, a reduction in the need for invasive mechanical ventilation (with objective criteria), and a reduction in in-hospital mortality [10].
  • In-hospital mortality for QMV, MVR, and MVP was 1, 0, and 0 patients, respectively, and thoracotomy had to be performed again in 1, 1, and 2 patients, respectively (these outcomes were not valve related) [11].

Chemical compound and disease context of Hospital Mortality


Biological context of Hospital Mortality


Anatomical context of Hospital Mortality


Associations of Hospital Mortality with chemical compounds

  • Mediastinal drainage was slightly higher (p = 0.04) in the aspirin plus dipyridamole group (713 +/- 456 ml) than in the other two groups (placebo, 670 +/- 437 ml; aspirin, 629 +/- 337 ml), but hospital mortality (average, 4.6%) and early reoperation (average, 3.9%) rates were similar among the three groups [25].
  • The hospital mortality rate was 12% (3/25) in the terlipressin group and 32% (8/25) in the control group [26].
  • Acute physiology, age, chronic health evaluation III score, and cortisol increment were independent factors to predict hospital mortality [27].
  • PATIENTS AND METHODS: Derivation-validation set methods were used in 1,826 consecutive patients undergoing coronary intervention with evaluation of baseline creatinine clearance (CrCl), diabetic status, contrast exposure, postprocedure creatinine, ARF, ARFD, in-hospital mortality, and long-term survival (derivation set) [28].
  • A maximal arterial lactate concentration of more than 2.2 mM was significantly associated with hospital mortality [29].

Gene context of Hospital Mortality

  • Elevated MYO significantly predicted in-hospital mortality (OR 25, 95% CI 1.3-474.2), while increased cTnT concentration did not affect the survival [30].
  • Subjects with a shortened activated partial thromboplastin time show increased in-hospital mortality associated with elevated D-dimer, C-reactive protein and glucose levels [31].
  • Ultimate hospital mortality was 9/33 (27.3%) in the +Fn group versus 13/34 (38.2%) in the -Fn group (p = 0.244, Fisher's exact test) [32].
  • Hospital mortality was statistically greater for patients with bloodstream infections due to P aeruginosa (n = 49) compared to methicillin-sensitive S aureus (MSSA) [n = 117; 30.6% vs 16.2%, p = 0.036] and methicillin-resistant S aureus (MRSA) [n = 148; 30.6% vs 13.5%, p = 0.007] [33].
  • The low hospital mortality and encouraging early follow-up data represent a significant improvement over atrial level repairs, supporting the arterial switch operation as the procedure of choice for children who have transposition of the great arteries with ventricular septal defect or double outlet ventricle [34].

Analytical, diagnostic and therapeutic context of Hospital Mortality

  • SUMMARY BACKGROUND DATA: In recent years, hepatectomy has been performed with a mortality rate of <10% in patients with HCC, but a zero hospital mortality rate in a large patient series has never been reported [35].
  • Overall, in-hospital mortality was 18.0%, and there was no significant difference between those who had coronary angiography on the day of surgery compared with those who had not (No: 16%, n = 81 vs. Yes: 22%, n = 41, p = 0.46) [36].
  • Total parenteral nutrition, including fish oil (mean, 0.11, was administered for 8.7 +/- 7.5 days and lowered hospital mortality as predicted by Simplified Acute Physiology Score II from 18.9% (95% confidence interval, 17.4-20.4%) to 12.0% (p < .001) [37].
  • Patients with nephritis also had lower risks of in-hospital mortality if they were hospitalized at highly experienced hospitals, but this risk did not differ in subgroups with other SLE manifestations or subgroups with different principal reasons for hospitalization [38].
  • Intensive management of blood glucose levels was reflected in a 43% reduction in intensive care mortality risk (P=0.036 after correction for interim analyses) and a 34% reduction in hospital mortality (P=0.01) [39].


  1. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Capes, S.E., Hunt, D., Malmberg, K., Gerstein, H.C. Lancet (2000) [Pubmed]
  2. Mitral valve replacement combined with myocardial revascularization: early and late results for 300 patients, 1970 to 1983. Lytle, B.W., Cosgrove, D.M., Gill, C.C., Stewart, R.W., Golding, L.A., Goormastic, M., Taylor, P.C., Loop, F.D. Circulation (1985) [Pubmed]
  3. A prospective evaluation of bacteremic patients with chronic liver disease. Barnes, P.F., Arevalo, C., Chan, L.S., Wong, S.F., Reynolds, T.B. Hepatology (1988) [Pubmed]
  4. Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction. Garratt, K.N., Brady, P.A., Hassinger, N.L., Grill, D.E., Terzic, A., Holmes, D.R. J. Am. Coll. Cardiol. (1999) [Pubmed]
  5. Factors related to in-hospital deaths in patients with tuberculosis. Sacks, L.V., Pendle, S. Arch. Intern. Med. (1998) [Pubmed]
  6. Clinical profiles and outcomes of acute type B aortic dissection in the current era: lessons from the International Registry of Aortic Dissection (IRAD). Suzuki, T., Mehta, R.H., Ince, H., Nagai, R., Sakomura, Y., Weber, F., Sumiyoshi, T., Bossone, E., Trimarchi, S., Cooper, J.V., Smith, D.E., Isselbacher, E.M., Eagle, K.A., Nienaber, C.A. Circulation (2003) [Pubmed]
  7. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group. Grines, C.L., Browne, K.F., Marco, J., Rothbaum, D., Stone, G.W., O'Keefe, J., Overlie, P., Donohue, B., Chelliah, N., Timmis, G.C. N. Engl. J. Med. (1993) [Pubmed]
  8. Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary disease. Seneff, M.G., Wagner, D.P., Wagner, R.P., Zimmerman, J.E., Knaus, W.A. JAMA (1995) [Pubmed]
  9. The relation between hospital experience and in-hospital mortality for patients with AIDS-related PCP. Bennett, C.L., Garfinkle, J.B., Greenfield, S., Draper, D., Rogers, W., Mathews, C., Kanouse, D.E. JAMA (1989) [Pubmed]
  10. Early use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomised controlled trial. Plant, P.K., Owen, J.L., Elliott, M.W. Lancet (2000) [Pubmed]
  11. Early clinical results after stentless mitral valve implantation and comparison with conventional valve repair or replacement. Walther, T., Walther, C., Falk, V., Diegeler, A., Krakor, R., Schneider, J., Autschbach, R., Mohr, F.W. Circulation (1999) [Pubmed]
  12. Role of metformin accumulation in metformin-associated lactic acidosis. Lalau, J.D., Lacroix, C., Compagnon, P., de Cagny, B., Rigaud, J.P., Bleichner, G., Chauveau, P., Dulbecco, P., Guérin, C., Haegy, J.M. Diabetes Care (1995) [Pubmed]
  13. Severity prediction rules in community acquired pneumonia: a validation study. Lim, W.S., Lewis, S., Macfarlane, J.T. Thorax (2000) [Pubmed]
  14. Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis. Kasiakou, S.K., Michalopoulos, A., Soteriades, E.S., Samonis, G., Sermaides, G.J., Falagas, M.E. Antimicrob. Agents Chemother. (2005) [Pubmed]
  15. Restriction of third-generation cephalosporin use decreases infection-related mortality. Du, B., Chen, D., Liu, D., Long, Y., Shi, Y., Wang, H., Rui, X., Cui, N. Crit. Care Med. (2003) [Pubmed]
  16. Oxygen delivery as a factor in the development of fatal postoperative complications after oesophagectomy. Kusano, C., Baba, M., Takao, S., Sane, S., Shimada, M., Shirao, K., Natsugoe, S., Fukumoto, T., Aikou, T. The British journal of surgery. (1997) [Pubmed]
  17. Pulmonary hypertension in mitral valve disease: 56 surgical patients reviewed. Manners, J.M., Monro, J.L., Ross, J.K. Thorax (1977) [Pubmed]
  18. Intraoperative physiologic variables and outcome in cardiac surgery: Part I. In-hospital mortality. Hill, S.E., van Wermeskerken, G.K., Lardenoye, J.W., Phillips-Bute, B., Smith, P.K., Reves, J.G., Newman, M.F. Ann. Thorac. Surg. (2000) [Pubmed]
  19. The special injury pattern in terrorist bombings. Kluger, Y., Peleg, K., Daniel-Aharonson, L., Mayo, A. J. Am. Coll. Surg. (2004) [Pubmed]
  20. Prognostic factors in acute cardiogenic pulmonary edema. Le Conte, P., Coutant, V., N'Guyen, J.M., Baron, D., Touze, M.D., Potel, G. The American journal of emergency medicine. (1999) [Pubmed]
  21. Hemodynamic changes after protamine administration: association with mortality after coronary artery bypass surgery. Welsby, I.J., Newman, M.F., Phillips-Bute, B., Messier, R.H., Kakkis, E.D., Stafford-Smith, M. Anesthesiology (2005) [Pubmed]
  22. Port-access approach for cardiac surgical procedures: our experience in 776 patients. Mishra, Y.K., Khanna, S.N., Wasir, H., Sharma, K.K., Mehta, Y., Trehan, N. Indian heart journal. (2005) [Pubmed]
  23. Aortic valve replacement with concomitant open mitral valvotomy--early results and long term followup in 72 consecutive patients. Kaul, P., John, S., John, C.N., Bashi, V.V., Ravikumar, E., Choudhry, U., Krishnaswamy, S. Indian heart journal. (1993) [Pubmed]
  24. The extent of akinesis is predictive of the in-hospital mortality from endoaneurysmorrhaphy. Bechtel, J.F., Tölg, R., Robinson, D.R., Graf, B., Richardt, G., Sievers, H.H., Kraatz, E.G. Zeitschrift für Kardiologie. (2005) [Pubmed]
  25. Prevention of early aortocoronary bypass occlusion by low-dose aspirin and dipyridamole. Grupo Español para el Seguimiento del Injerto Coronario (GESIC). Sanz, G., Pajarón, A., Alegría, E., Coello, I., Cardona, M., Fournier, J.A., Gómez-Recio, M., Ruano, J., Hidalgo, R., Medina, A. Circulation (1990) [Pubmed]
  26. Terlipressin in bleeding esophageal varices: a placebo-controlled, double-blind study. Walker, S., Stiehl, A., Raedsch, R., Kommerell, B. Hepatology (1986) [Pubmed]
  27. Adrenal insufficiency in patients with cirrhosis, severe sepsis and septic shock. Tsai, M.H., Peng, Y.S., Chen, Y.C., Liu, N.J., Ho, Y.P., Fang, J.T., Lien, J.M., Yang, C., Chen, P.C., Wu, C.S. Hepatology (2006) [Pubmed]
  28. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. McCullough, P.A., Wolyn, R., Rocher, L.L., Levin, R.N., O'Neill, W.W. Am. J. Med. (1997) [Pubmed]
  29. Significance of blood lactate levels in critically ill patients with liver disease. Kruse, J.A., Zaidi, S.A., Carlson, R.W. Am. J. Med. (1987) [Pubmed]
  30. Myoglobin stratifies short-term risk in acute major pulmonary embolism. Pruszczyk, P., Bochowicz, A., Kostrubiec, M., Torbicki, A., Szulc, M., Gurba, H., Kuczynska, K., Berent, H. Clin. Chim. Acta (2003) [Pubmed]
  31. Subjects with a shortened activated partial thromboplastin time show increased in-hospital mortality associated with elevated D-dimer, C-reactive protein and glucose levels. ten Boekel, E., de Kieviet, W., Bartels, P.C. Scand. J. Clin. Lab. Invest. (2003) [Pubmed]
  32. Purified fibronectin administration to patients with severe abdominal infections. A controlled clinical trial. Lundsgaard-Hansen, P., Doran, J.E., Rubli, E., Papp, E., Morgenthaler, J.J., Späth, P. Ann. Surg. (1985) [Pubmed]
  33. Hospital mortality for patients with bacteremia due to Staphylococcus aureus or Pseudomonas aeruginosa. Osmon, S., Ward, S., Fraser, V.J., Kollef, M.H. Chest (2004) [Pubmed]
  34. Results of the arterial switch operation for transposition of the great arteries with ventricular septal defect. Surgical considerations and midterm follow-up data. Di Donato, R.M., Wernovsky, G., Walsh, E.P., Colan, S.D., Lang, P., Wessel, D.L., Jonas, R.A., Mayer, J.E., Castañeda, A.R. Circulation (1989) [Pubmed]
  35. Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. Fan, S.T., Lo, C.M., Liu, C.L., Lam, C.M., Yuen, W.K., Yeung, C., Wong, J. Ann. Surg. (1999) [Pubmed]
  36. Does coronary angiography before emergency aortic surgery affect in-hospital mortality? Penn, M.S., Smedira, N., Lytle, B., Brener, S.J. J. Am. Coll. Cardiol. (2000) [Pubmed]
  37. Omega-3 fatty acids improve the diagnosis-related clinical outcome. Heller, A.R., Rössler, S., Litz, R.J., Stehr, S.N., Heller, S.C., Koch, R., Koch, T. Crit. Care Med. (2006) [Pubmed]
  38. Hospital experience and mortality in patients with systemic lupus erythematosus: which patients benefit most from treatment at highly experienced hospitals? Ward, M.M. J. Rheumatol. (2002) [Pubmed]
  39. Beyond diabetes: saving lives with insulin in the ICU. Van den Berghe, G. Int. J. Obes. Relat. Metab. Disord. (2002) [Pubmed]
WikiGenes - Universities